Technology | October 16, 2007

The syngo MammoCAD was created for full-field digital mammography and the detection of masses and microcalcifications to help radiologists detect breast cancer in its earliest and most treatable form. The system reportedly provides low rates of false positive marks with up to 40 percent of normal cases having no false positive detections at all.

The device generates CAD marks to highlight suspicious areas in the mammogram, such as masses and microcalcifications. The CAD tool is reportedly designed for excellent workflow efficiency. With an average of less than 60 seconds processing time per set of four images, syngo MammoCAD is optimized for high volume throughput. The product is integrated with the syngo CAD Manager, a Siemens CAD server solution.


Additional Content

News | Radiology Business

June 6, 2023 — RaySearch Laboratories has announced that New York University (NYU) Langone Hospital - Long Island ...

Time June 06, 2023
arrow
News | Radiology Business

January 18, 2023 — Addressing the growing demand for medical imaging and a shortage of radiologists, Bayer announced the ...

Time January 18, 2023
arrow
News | Artificial Intelligence

December 14, 2022 — Dallas, TX-based MedCognetics, Inc. announced it has received U.S Food and Drug Administration (FDA) ...

Time December 14, 2022
arrow
News | Breast Imaging

November 25, 2022 — Hologic, Inc. will exhibit its extensive portfolio of breast and skeletal health products at the ...

Time November 25, 2022
arrow
News | Digital Pathology

September 13, 2022 — Deciphex, a Dublin, Ireland-based provider of digital pathology software and services, has ...

Time September 13, 2022
arrow
Subscribe Now